PepEvolution
HomeRankingsMelanotan I
SkinPreliminary grade

Melanotan I

Afamelanotide / Scenesse

FDA-approved 2019 (Scenesse) for a rare sun-sensitivity disorder — the clinically validated melanocortin agonist, but not for tanning.

Verdict — C · Emerging / Mixed

A real FDA approval for a narrow rare disease, with phase-3 evidence. The gray-market tanning use is unapproved and carries a milder but similar melanocytic concern to MT-II. The clinical pathway (EPP) is well-validated; the recreational pathway is not. Gray-market supply is extremely limited.

Overview

Melanotan I (afamelanotide, Scenesse) is a linear alpha-MSH analogue FDA-approved in 2019 for erythropoietic protoporphyria (EPP), a rare disorder causing severe pain upon sun exposure. Unlike Melanotan II it lacks the potent sexual/erectile activity but still stimulates eumelanin production. The approved indication has solid phase-3 RCT support; the gray-market tanning use case is a completely different and unapproved application. Sourcing outside an EPP prescription is essentially gray-market only.

PepScore Breakdown — the four axes

Evidence

35% weight
72/100

How strong is the published human science?

Human data depth26/40
Regulatory & registry status24/30
Reproducibility & consistency14/20
Mechanism characterized in humans8/10

Sourcing & COA

30% weightOur moat
42/100

Can a buyer obtain an independently-verified, high-purity version? — our proprietary layer.

Independent 3rd-party testing15/35
Verified purity %13/30
COA transparency & batch traceability8/20
Multi-vendor verified availability6/15

Safety & Risk

25% weight
61/100

What is the real-world harm potential?

Documented AEs / toxicity24/40
Contraindication breadth15/25
Regulatory warnings12/20
Therapeutic index / margin10/15

Practicality

10% weight
49/100

How easy is it to actually run a verified version?

Verified-source availability14/35
Cost / value per cycle10/25
Reconstitution & administration16/25
Storage & stability9/15

Sources & Citations

Every claim cites a primary source. Citations are machine-audited against NCBI — see methodology.

Want a clinical path?

Talk to a licensed provider about Melanotan I and whether it's appropriate for your situation.

Talk to a Provider ↗

Telehealth. Not medical advice — for educational purposes.

PepScore58/100 · C
Last gradedJune 28, 2026
Next re-grade triggerA licensed Rx path for EPP would be the only clean sourcing option; a comparative safety study for off-label tanning vs MT-II would inform the Safety score.

Get the PepEvolution Dispatch

Monthly COA findings, vendor changes, and new grades. Research/educational only — no spam.

Free. Unsubscribe anytime. Research/educational content only.

Educational only — not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links — this never affects grades. Consult a licensed healthcare provider before using any compound.